BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers

  October 21, 2024

   · 

  9 min read
• Press Releases

  BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma

  October 21, 2024

   · 

  9 min read
• Press Releases

  BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024

  October 21, 2024

   · 

  2 min read
• Press Releases

  Kraig Biocraft Laboratories to Host Upcoming Investor Web Conference Highlighting Commercialization Progress of Spider Silk Technologies

  October 21, 2024

   · 

  2 min read
• Press Releases

  Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024

  October 21, 2024

   · 

  1 min read
• Press Releases

  Akero Therapeutics to Present Data Reinforcing the Efficacy of Efruxifermin at the 75th Annual AASLD The Liver Meeting® 2024

  October 21, 2024

   · 

  2 min read
• Press Releases

  Skye Bioscience to Participate in Upcoming November 2024 Healthcare Investment Conferences

  October 21, 2024

   · 

  3 min read
• Press Releases

  Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

  October 21, 2024

   · 

  9 min read
• Press Releases

  BeiGene Canada Proud National Sponsor of the Leukemia & Lymphoma Society of Canada’s 2024 Light The Night

  October 21, 2024

   · 

  2 min read
• Press Releases

  Arcutis Canada Announces Health Canada Approval of ZORYVE® Foam to Treat Seborrheic Dermatitis in Individuals 9 Years of Age and Older

  October 21, 2024

   · 

  9 min read